122 related articles for article (PubMed ID: 37864896)
1. Integration of metabolomics and transcriptomics reveals metformin suppresses thyroid cancer progression via inhibiting glycolysis and restraining DNA replication.
Ouyang J; Feng Y; Zhang Y; Liu Y; Li S; Wang J; Tan L; Zou L
Biomed Pharmacother; 2023 Dec; 168():115659. PubMed ID: 37864896
[TBL] [Abstract][Full Text] [Related]
2. Glucose-deprivation increases thyroid cancer cells sensitivity to metformin.
Bikas A; Jensen K; Patel A; Costello J; McDaniel D; Klubo-Gwiezdzinska J; Larin O; Hoperia V; Burman KD; Boyle L; Wartofsky L; Vasko V
Endocr Relat Cancer; 2015 Dec; 22(6):919-32. PubMed ID: 26362676
[TBL] [Abstract][Full Text] [Related]
3. Metformin inhibits thyroid cancer cell growth, migration, and EMT through the mTOR pathway.
Han B; Cui H; Kang L; Zhang X; Jin Z; Lu L; Fan Z
Tumour Biol; 2015 Aug; 36(8):6295-304. PubMed ID: 25854169
[TBL] [Abstract][Full Text] [Related]
4. Metformin attenuates hepatoma cell proliferation by decreasing glycolytic flux through the HIF-1α/PFKFB3/PFK1 pathway.
Hu L; Zeng Z; Xia Q; Liu Z; Feng X; Chen J; Huang M; Chen L; Fang Z; Liu Q; Zeng H; Zhou X; Liu J
Life Sci; 2019 Dec; 239():116966. PubMed ID: 31626790
[TBL] [Abstract][Full Text] [Related]
5. Metformin suppressed the proliferation of LoVo cells and induced a time-dependent metabolic and transcriptional alteration.
He J; Wang K; Zheng N; Qiu Y; Xie G; Su M; Jia W; Li H
Sci Rep; 2015 Nov; 5():17423. PubMed ID: 26616174
[TBL] [Abstract][Full Text] [Related]
6. Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents.
Chen G; Xu S; Renko K; Derwahl M
J Clin Endocrinol Metab; 2012 Apr; 97(4):E510-20. PubMed ID: 22278418
[TBL] [Abstract][Full Text] [Related]
7. Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid Cancer
Thakur S; Daley B; Gaskins K; Vasko VV; Boufraqech M; Patel D; Sourbier C; Reece J; Cheng SY; Kebebew E; Agarwal S; Klubo-Gwiezdzinska J
Clin Cancer Res; 2018 Aug; 24(16):4030-4043. PubMed ID: 29691295
[No Abstract] [Full Text] [Related]
8. Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis while Metformin Downregulates HIF-1α-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines.
Tyszka-Czochara M; Bukowska-Strakova K; Kocemba-Pilarczyk KA; Majka M
Nutrients; 2018 Jun; 10(7):. PubMed ID: 29958416
[TBL] [Abstract][Full Text] [Related]
9. Metformin induces TPC-1 cell apoptosis through endoplasmic reticulum stress-associated pathways in vitro and in vivo.
Ye J; Qi L; Chen K; Li R; Song S; Zhou C; Zhai W
Int J Oncol; 2019 Jul; 55(1):331-339. PubMed ID: 31180536
[TBL] [Abstract][Full Text] [Related]
10. Metformin Inhibits TGF-β1-Induced Epithelial-to-Mesenchymal Transition via PKM2 Relative-mTOR/p70s6k Signaling Pathway in Cervical Carcinoma Cells.
Cheng K; Hao M
Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27916907
[TBL] [Abstract][Full Text] [Related]
11. Metformin Induces Oxidative Stress-Mediated Apoptosis without the Blockade of Glycolysis in H4IIE Hepatocellular Carcinoma Cells.
Park D
Biol Pharm Bull; 2019; 42(12):2002-2008. PubMed ID: 31787716
[TBL] [Abstract][Full Text] [Related]
12. Low glucose enhanced metformin's inhibitory effect on pancreatic cancer cells by suppressing glycolysis and inducing energy stress via up-regulation of miR-210-5p.
Ma M; Ma C; Li P; Ma C; Ping F; Li W; Xu L; Zhang H; Sun Q; Li Y
Cell Cycle; 2020 Sep; 19(17):2168-2181. PubMed ID: 32718270
[TBL] [Abstract][Full Text] [Related]
13. Effects of metformin on the PI3K/AKT/FOXO1 pathway in anaplastic thyroid Cancer cell lines.
Nozhat Z; Mohammadi-Yeganeh S; Azizi F; Zarkesh M; Hedayati M
Daru; 2018 Dec; 26(2):93-103. PubMed ID: 30242671
[TBL] [Abstract][Full Text] [Related]
14. Co-treatment of breast cancer cells with pharmacologic doses of 2-deoxy-D-glucose and metformin: Starving tumors.
Wokoun U; Hellriegel M; Emons G; Gründker C
Oncol Rep; 2017 Apr; 37(4):2418-2424. PubMed ID: 28350075
[TBL] [Abstract][Full Text] [Related]
15. Metformin reduces glycometabolism of papillary thyroid carcinoma in vitro and in vivo.
Shen CT; Wei WJ; Qiu ZL; Song HJ; Zhang XY; Sun ZK; Luo QY
J Mol Endocrinol; 2017 Jan; 58(1):15-23. PubMed ID: 27920093
[TBL] [Abstract][Full Text] [Related]
16. [The mechanism of aspirin combined with metformin induced apoptosis of thyroid cancer TPC-1 cells].
Qi L; Ye JW; Xue WH; Tian X; Zhang HJ
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):276-281. PubMed ID: 31014052
[No Abstract] [Full Text] [Related]
17. Metformin Reduces Thyroid Cancer Tumor Growth in the Metastatic Niche of Bone by Inhibiting Osteoblastic RANKL Productions.
Shin HS; Sun HJ; Whang YM; Park YJ; Park DJ; Cho SW
Thyroid; 2021 May; 31(5):760-771. PubMed ID: 32791889
[No Abstract] [Full Text] [Related]
18. FOXA2 suppresses PKM2 transcription and affects the Wnt/β-catenin activity to block aerobic glycolysis in thyroid carcinoma.
He Y; Chen W; Yu L; Liu Y; Cheng Y; Li X; Yu G
Clin Exp Pharmacol Physiol; 2023 Jul; 50(7):561-572. PubMed ID: 36946190
[TBL] [Abstract][Full Text] [Related]
19. MiR-886-3p regulates cell proliferation and migration, and is dysregulated in familial non-medullary thyroid cancer.
Xiong Y; Zhang L; Holloway AK; Wu X; Su L; Kebebew E
PLoS One; 2011; 6(10):e24717. PubMed ID: 21998631
[TBL] [Abstract][Full Text] [Related]
20. Metabolomics profiling of metformin-mediated metabolic reprogramming bypassing AMPKα.
Yan M; Qi H; Xia T; Zhao X; Wang W; Wang Z; Lu C; Ning Z; Chen H; Li T; Tekcham DS; Liu X; Liu J; Chen D; Liu X; Xu G; Piao HL
Metabolism; 2019 Feb; 91():18-29. PubMed ID: 30468782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
